<bill session="109" type="h" number="5369" updated="2023-01-13T04:48:29Z">
  <state datetime="2006-05-11">REFERRED</state>
  <status>
    <introduced datetime="2006-05-11"/>
  </status>
  <introduced datetime="2006-05-11"/>
  <titles>
    <title type="display">Medicare Clinical Laboratory Fee Schedule Improvement Act of 2006</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule.</title>
    <title type="short" as="introduced">Medicare Clinical Laboratory Fee Schedule Improvement Act of 2006</title>
  </titles>
  <sponsor bioguide_id="F000443"/>
  <cosponsors>
    <cosponsor bioguide_id="C001051" joined="2006-11-15"/>
    <cosponsor bioguide_id="E000187" joined="2006-05-11"/>
    <cosponsor bioguide_id="P000149" joined="2006-06-28"/>
    <cosponsor bioguide_id="P000555" joined="2006-11-15"/>
    <cosponsor bioguide_id="R000515" joined="2006-05-11"/>
    <cosponsor bioguide_id="S001143" joined="2006-07-25"/>
    <cosponsor bioguide_id="T000460" joined="2006-05-11"/>
  </cosponsors>
  <actions>
    <action datetime="2006-05-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2006-05-11" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2006-05-11">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2006-06-05">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Congressional reporting requirements"/>
    <term name="DNA"/>
    <term name="Department of Health and Human Services"/>
    <term name="Evidence (Law)"/>
    <term name="Federal advisory bodies"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Law"/>
    <term name="Medical fees"/>
    <term name="Medical laboratories"/>
    <term name="Medical tests"/>
    <term name="Medicare"/>
    <term name="Molecular biology"/>
    <term name="Proteins"/>
    <term name="Science, Technology, Communications"/>
    <term name="Social Welfare"/>
  </subjects>
  <amendments/>
  <summary date="2006-05-31T19:03:16Z" status="Introduced in House">Medicare Clinical Laboratory Fee Schedule Improvement Act of 2006 - Amends title XVIII (Medicare) of the Social Security Act with respect to: (1) correction of erroneous determinations and other changes in fee schedule and national limitation amounts for clinical diagnostic laboratory tests; (2) issuance of regulations on gap-filling methodology in determining the Medicare fee schedule for such tests; (3) increased transparency of process for determining fee schedule amounts for new tests; and (4) mandatory advance notice of clinical diagnostic laboratory test amounts being considered for adjustment under inherent reasonableness authority.

Directs the Secretary to: (1) establish a demonstration project to evaluate new approaches to coding and payment under the Medicare program for clinical diagnostic laboratory tests; and (2) appoint a standing panel to determine tests to be included in the project and make recommendations derived from project results to the Secretary of Health and Human Services.</summary>
</bill>
